Characterization of T-cell receptor β chain mRNA expression in IFN-α- responsive chronic myelogenous leukaemia patients

British Journal of Haematology

Volumn 105, Issue 1, 1999, Pages 173-180

  Shimomura, Taizo ^b   Fujii, Shin Ichiro ^a   Ezaki, Ichiko ^b   Osato, Motomi ^b   Fujimoto, Koji ^b   Takatsuki, Kiyoshi ^b   Yamamoto, Kazuhiko ^b   Kawakita, Makoto ^b  

^a NATIONAL HOSPITAL ORGANIZATION KUMAMOTO MEDICAL CENTER   (Japan)

^b NONE

Author keywords

CML; IFN ; Immune response; RT PCR SSCP; TCR repertoire

Indexed keywords

ALPHA INTERFERON; HYDROXYUREA;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER IMMUNOTHERAPY; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; DRUG EFFECT; FEMALE; HUMAN; IMMUNOREGULATION; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE STRAND CONFORMATION POLYMORPHISM; T LYMPHOCYTE ACTIVATION;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; INTERFERON-ALPHA; LEUKEMIA, MYELOID, CHRONIC; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TREATMENT OUTCOME;

EID: 0032943402     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2141.1999.01283.x     Document Type: Article

References (48)

1. 1-positive chronic myelogenous leukemia: a study of 82 patients treated with intermittent or daily administration. Blood, 72, 642-647.
2. Allan, N.C., Richards, S.M. & Shepherd, P.C. (1995) UK Medical Research Council randomised, multicentre trial of interferon-alpha n1 for chronic myeloid leukaemia: improved survival irrespective of cytogenetic response. The UK Medical Research Council's Working Parties for Therapeutic Trials in Adult Leukaemia. Lancet, 345, 1392-1397.
3. Bocchia, M., Wentworth, P.A., Southwood, S., Sidney, J., McGraw, K., Scheinberg, D.A. & Sette, A. (1995) Specific binding of leukemia oncogene fusion protein peptides to HLA class I molecules. Blood, 85, 2680-2684.
4. Calabretta, B., Battini, R., Kaczmarek, L., de Riel, J.K. & Baserga, R. (1986) Molecular cloning of the cDNA for a growth factor-inducible gene with strong homology to S-100, a calcium-binding protein. Journal of Biological Chemistry, 261, 12628-12632.
5. Choi, Y.W., Kotzin, B., Herron, L., Callahan, J., Marrack, P. & Kappler, J. (1989) Interaction of Staphylococcus aureus toxin 'superantigens' with human T cells. Proceedings of the National Academy of Sciences of the United States of America, 86, 8941-8945.
6. Choudhury, A., Toubert, A., Douay, C., Charron, D., Champlin, R. & Claxton, D. (1997) MHC restriction and preferential TCR Vβ usage in anti-leukemic T lymphocytes elicited against autologous, CML-derived dendritic cells from different CML patients. Blood, 90, (Suppl. I), 198a.
7. Claret, E.J., Alyea, E.P., Orsini, E., Pickett, C.C., Collins, H., Wang, Y., Neuberg, D., Soiffer, R.J. & Ritz, J. (1997) Characterization of T cell repertoire in patients with graft-versus-leukemia after donor lymphocyte infusion. Journal of Clinical Investigation, 100, 855-866.
8. Coleman, S., Perera, P., Fisher, J., Hoy, T., Burnett, A.K. & Lim, S.H. (1995) Abnormal TCR V beta repertoire in patients with chronic myeloid leukaemia. British Journal of Haematology, 90, 358-363.
9. Cross, N.C., Melo, J.V., Feng, L. & Goldman, J.M. (1994) An optimized multiplex polymerase chain reaction (PCR) for detection of BCR-ABL fusion mRNAs in haematological disorders. Leukemia, 8, 186-189.
10. Ellis, T.M., McKenzie, R.S., Simms, P.E., Helfrich, B.A. & Fisher, R.I. (1989) Induction of human lymphokine-activated killer cells by IFN-alpha and IFN-gamma. Journal of Immunology, 143, 4282-4286.
11. Faber, L.M., van Luxemburg-Heijs, S.A., Willemze, R. & Falkenburg, J.H. (1992) Generation of leukemia-reactive cytotoxic T lymphocyte clones from the HLA-identical bone marrow donor of a patient with leukemia. Journal of Experimental Medicine, 176, 1283-1289.
12. Giralt, S., Kantarjian, H. & Talpaz, M. (1995) The natural history of chronic myelogenous leukemia in the interferon era. Seminars in Hematology, 32, 152-158.
13. Groffen, J. & Heisterkamp, N. (1987) The BCR/ABL hybrid gene. Bailliere's Clinical Haematology, 1, 983-999
14. Goldman, J.M., Gale, R.P., Horowitz, M.M., Biggs, J.C., Champlin, R.E., Gluckman, E., Hoffmann, R.G., Jacobsen, S.J., Marmont, A.M., McGlave, P.B., Messner, H.A., Rimm, A.A., Rozman, C., Speck, B., Tura, S., Weiner, R.S. & Bortin, M.M. (1988) Bone marrow transplantation for chronic myelogenous leukemia in chronic phase: increased risk for relapse associated with T-cell depletion. Annals of Internal Medicine, 108, 806-814.
15. Gutterman, J.U. (1994) Cytokine therapeutics: lessons from interferon alpha. Proceedings of the National Academy of Sciences of the United States of America, 91, 1198-1205.
16. Hehlmann, R., Heimpe, H., Kolb, H.J., Heinze, B., Hochhaus, A., Griesshammer, M., Pralle, H., Queisser, W.P.D., Essers, U., Falge, C., Bergmann, L., Queisser, U., Meyer, P., Schmitz, N., Wickramanayake, P.D., Walther, K, Westerhausen, M., Kleeberg, U.R., Heilein.,A., Kabisch, A., Heiss, F., Zimmermenn, R., Meuret, G., Tichelli, A., Berdel, W.E., Tigges, F-J., Eimermacher, H., Schmid, L., Zankovich, R., Thiele, J., Lofller, H., Wussow, Pv., Buhr, T., Gergii, A., Hossfeld, D.K., Ansari, H. & Hasford, J. (1993) The German CML study, comparison of busulfan vs. hydroxyurea vs. interferon alpha and establishment of prognostic score 1. Leukemia and Lymphoma, 11, (Suppl. I), 159-168.
17. Keating, A. (1993) Investigation of ber-abl transcription by Ph-positive chronic myeloid leukemia progenitors. Stem Cells, 3, 31-33.
18. Kloke, O., Niederle, N., Qiu, J.Y., Wandl, U., Moritz, T., Nagel-Hiemke, M., Hawig, I., Opalka, B., Seeber, S. & Becher, R. (1993) Impact of interferon alpha-induced cytogenetic improvement on survival in chronic myelogenous leukaemia. British Journal of Haematology, 83, 599-403.
19. Kolb, H.J., Mittermuller, J., Clemm, C., Holler, E., Ledderose, G., Brehm, G., Heim, M. & Wilmanns, W. (1990) Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood, 76, 2462-2465.
20. Lee, S.W., Tomasetto, C. & Sager, R. (1991) Positive selection of candidate tumor-suppressor genes by subtractive hybridization. Proceedings of the National Academy of Sciences of the United States of America, 88, 1825-1829.
21. McGahon, A., Bissonnette, R., Schmitt, M., Cotter, K.M., Green, D.R. & Cotter, T.G. (1994) BCR-ABL maintains resistance of chronic myelogenous leukemia cells to apoptotic cell death. Blood, 83, 1179-1187.
22. McGlave, P.B., Messener, H.A., Rimm, A.A., Rozman, C., Speck, B., Tura, S., Weiner, R.S. & Bortin, M.M. (1988) Bone marrow transplantation for chronic myelogenous leukemia in chronic phase: increased risk for relapse associated with T-cell depletion. Annals of Internal Medicine, 108, 806-814.
23. McWhirter, J.K. & Wang, J.Y. (1993) An actin-binding function contributes to transformation by the Ber-Abl oncoprotein of Philadelphia chromosome-positive human leukemias. EMBO Journal, 12, 1533-1446.
24. Merrouche, Y., Negrier, S., Puisieux, I. & Favrot, M. (1997) Can we define the mechanism of antitumor response observed during clinical adoptive immunotherapy? Journal of the National Cancer Institute, 89, 1380-1381.
25. Meseri, A., Delwail, V., Brizard, A., Lecron, J.C., Pelletier, D., Guilhot, F., Tanzer, J. & Goube de Laforest, P. (1993) Endogenous lymphokine activated killer cell activity and cytogenetic response in chronic myelogenous leukaemia treated with alpha-interferon. British Journal of Haematology 83, 218-222.
26. Nakamuru, Y., Hirosawa, S. & Aoki, N. (1993) Consistent involvement of the 3′ half part of the first BCR intron in adult Philadelphia-positive leukaemia without M-ber rearrangement. British Journal of Haematology, 83, 53-57.
27. Niederle, N., Kloke, O., Osieka, R., Wandl, U., Opalka, B. & Schmidt, C.G. (1987) Interferon alfa-2b in the treatment of chronic myelogenous leukemia. Seminars in Oncology, 14, 29-35.
28. Niederle, N., Kloke, O., Wandl, U.B., Becher, R., Moritz, T. & Opalka, B. (1993) Long-term treatment of chronic myelogenous leukemia with different interferons: results from three studies. Leukemia and Lymphoma, 111-119.
29. Opalka, B., Wandl, U., Beer, U., Roggenbuck, U., Kloke, O. & Niederle, N. (1991a.) Breakpoint localization within the M-ber and clinical course do not correlate in patients with chronic myclogenous leukemia undergoing alfa Interferon therapy. Leukemia 5, 452-456.
30. Opalka, B., Wandl, U.B., Becher, R., Kloke, O., Nagel-Hiemke, M., Moritz, T., Beer, U., Seeber, S. & Niederle, N. (1991b) Minimal residual disease in patients with chronic myelogenous leukemia undergoing long-term treatment with recombinant interferon alpha-2b alone or in combination with interferon gamma. Blood, 78, 2188-2193.
31. Ozer, H., George, S.L., Schiffer, C.A., Rao, K., Rao, P.N., Wurster-Hill, D.H., Arthur, D.D., Powell, B., Gottlieb, A., Peterson, B.A., Rai, K., Testa, J.R., LeBeau, M., Tantravahi, R. & Bloomfield, C.D. (1993) Prolonged subcutaneous administration of recombinant alpha 2b interferon in patients with previously untreated Philadelphia chromosome-positive chronic-phase chronic myelogenous leukemia: effect on remission duration and survival: Cancer and Leukemia Group B study 8583. Blood, 82, 2975-2984.
32. Pawelec, G., Max, H., Halder, T., Bruscrud, O., Merl, A., de Silva, P. & Kalbacher, H. (1996) BCR/ABL leukemia oncogene fusion peptides selectively bind to certain HLA-DR alleles and can be recognized by T cells found at low frequency in the repertoire of normal donors. Blood, 88, 2118-2124
33. Pendergast, A.M., Quilliam, L.A., Cripe, L.D., Bassing, C.H., Dai, Z., Li, N., Batzer, A., Rabun, K.M., Der, C.J., Schlessinger, J. & Gishizky, M.L. (1993) BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein. Cell, 75, 175-185.
34. Puisieux, I., Bain, C., Merrouche, Y., Malacher, P., Kourilsky, P., Even, J. & Favrot, M. (1996) Restriction of the T-cell repertoire in tumor-infiltrating lymphocytes from nine patients with renal-cell carcinoma: relevance of the CDR3 length analysis for the identification of in situ clonal T-cell expansions. International Journal of Cancer, 66, 201-208.
35. Romagnani, S. (1992) Induction of TH1 and TH2 responses: a key role for the 'natural' immune response? Immunology Today, 13, 379-381.
36. Rowley, J.D. (1973) A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. (Letter). Nature, 243, 290-293.
37. Santucci, M.A., Soligo, D., Pileri, S., Zuffa, E., Testoni, N. & Tura, S. (1993) Interferon-alpha effects on stromal compartment of normal and chronic myeloid leukemia hematopoiesis. Leukemia and Lymphoma, 1, (Suppl. 1), 113-118.
38. Schmidt, H., Kellermann-Kegreiss, E., Steiert, I., Walz, J., Zinser, R. & Muller, C.A. (1993) Differential regulation of human leukocyte antigen class I genes by interferon in vivo and in vitro. Journal of Immunotherapy, 14, 169-174.
39. Selleri, L., von Lindern, M., Hermans, A., Meijer, D., Torelli, G. & Grosveld, G. (1990) Chronic myeloid leukemia may be associated with several bcr-abl transcripts including the acute lymphoid leukemia-type 7 kb transcript. Blood, 75, 1146-1153.
40. Shepherd, P., Suffolk, R., Halsey, J. & Allan, N. (1995) Analysis of molecular breakpoint and m-RNA transcripts in a prospective randomized trial of interferon in chronic myeloid leukaemia: no correlation with clinical features, cytogenetic response, duration of chronic phase, or survival. British Journal of Haematology, 89, 546-554.
41. Soekarman, D., van Denderen, J., Hoefsloot, L., Moret, M., Meeuwsen, T., van Baal, J., Hagemeijer, A. & Grosveld, G. (1990) A novel variant of the bcr-abl fusion product in Philadelphia chromosome-positive acute lymphoblastic leukemia. Leukemia, 4, 397-403.
42. Talpaz, M., Kantarjian, H., Kurzrock, R., Trujillo, J.M. & Gutterman, J.U. (1991) Interferon-alpha produces sustained cytogenetic responses in chronic myelogenous leukemia: Philadelphia chromosome-positive patients. Annals of Internal Medicine, 114, 532-538.
43. Talpaz, M., Kantarjian, H.M., McCredie, K., Trujillo, J.M., Keating, M.J. & Gutterman, J.U. (1986) Hematologic remission and cytogenetic improvement induced by recombinant human interferon alpha A in chronic myelogenous leukemia. New England Journal of Medicine, 314, 1065-1069.
44. Talpaz, M., McCredie, K.B., Mavligit, G.M. & Gutterman, J.U. (1983) Leukocyte interferon-induced myeloid cytoreduction in chronic myelogenous leukemia. Blood, 62, 689-692.
45. ten Bosch, G.J., Toornvliet, A.C., Friede, T., Melief, C.J. & Leeksma, O.C. (1995) Recognition of peptides corresponding to the joining region of p210BCR-ABL protein by human T cells. Leukemia, 9, 1344-1348.
46. Villa, A., Santagata, S., Bozzi, F., Giliani, S., Frattini, A., Imberti, L., Gatta, L.B., Ochs, H.D., Schwarz, K., Notarangelo, L.D., Vezzoni, P. & Spanopoulou, E. (1998) Partial V(D)J recombination activity leads to Omenn syndrome. Cell, 93, 885-896.
47. Yamamoto, K., Sakoda, H., Nakajima, T., Kato, T., Okubo, M., Dohi, M., Mizushima, Y., Ito, K. & Nishioka, K. (1992) Accumulation of multiple T cell clonotypes in the synovial lesions of patients with rheumatoid arthritis revealed by a novel clonality analysis. International Immunology, 4, 1219-1223.
48. Zaccaria, A., Tassinari, A., Testoni, N., Lauria, F., Tura, S., Algeri, R., Guerrasio, A., Rosso, C. & Saglio, G. (1990) Alternative BCR/ABL transcripts in chronic myeloid leukemia. Blood, 76, 1663-1665.